Matrixx Initiatives notified the public of a recall of one lot of Zicam Extreme Congestion Relief nasal gel due to the detection of Burkholderia cepacia in a single sample from the affected lot. The contamination was detected during a routine review at the manufacturing facility.
The affected lot is 2J23 with an expiration date of 09/15. It is packaged in a 0.5oz spray bottle bearing NDC number 62750-005-10.
Burkholderia cepacia in a nasal spray could cause upper airway colonization and secondarily lead to respiratory infections in individuals with a compromised immune system or those with chronic lung conditions, such as cystic fibrosis.
Zicam Extreme Congestion Relief nasal gel contains oxymetazoline HCl 0.05%, a nasal decongestant.
For more information visit http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm332830.htm.